Business
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
SILICON VALLEY, CA - June 26, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology,...
About this update from Abvc Biopharma, Inc.
[{"type":"text","content":"SILICON VALLEY, CA - June 26, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, proudly announces that a podcast with Biotech Orbit (https://youtu.be/TYrNEA0mG-8?si=xnCCjK1ZrRIw8OK7), featured the Company's Chief Executive Officer, Dr. Uttam Patil, among their list of the most influential Indian-origin CEOs leading major global organizations.","length":529,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"ABVC BioPharma, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1920,"height":1080,"url":"https://media.zenfs.com/en/newsmediawire_165/8dc1c0fdf16412ceabf1558510af4628"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/45zGiWkFs7zn272LfjbiAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/8dc1c0fdf16412ceabf1558510af4628","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/tDZVlBSnndpi3pbOHgPeBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://media.zenfs.com/en/newsmediawire_165/8dc1c0fdf16412ceabf1558510af4628","width":1200,"height":675}}},{"type":"text","content":"On the podcast, Dr. Patil discussed the Company's flagship antidepressant candidate, ABV-1504, which is preparing to enter Phase III clinical trials. In the interview, Dr. Patil emphasized a critical differentiator found thus far in in-house trials of ABV-1504 the absence of suicidal ideation, a side effect commonly associated with conventional synthetic antidepressants.","length":377,"tagName":"p"},{"type":"text","content":""We believe ABV-1504 represents the potential for a new generation of safe, plant-derived psychiatric treatments," said Dr. Patil. He continued, "While the medical community remains cautious toward botanical drugs, we are hopeful that our clinical program will build the confidence needed to drive acceptance and adoption globally."","length":352,"tagName":"p"},{"type":"text","content":"Dr. Patil joins an exclusive group of Indian-origin CEOs leading major global institutions. His inclusion on the list underscores the rising influence of biotech executives with deep R&D roo...